Skip to main content

Table 2 Dietary intakes and physical activities of women with polycystic ovary syndrome compared to controls following a 24-week hypocaloric low glycemic index diet

From: The effects of weight loss on health-related quality of life in obese women with PCOS and controls

Variables

Baseline

p-value

(Baseline)

24 weeks

Δ 24–0 weeks

Within group

p-value

Between

group

p-value

Energy (Kcal)

      

PCOS (n = 105)

Controls (n = 111)

2318.3 ± 374.2

2279 ± 280

0.500

1442.5 ± 101.6

1453.4 ± 108

-875.8 ± 394.3

-825.5 ± 295.4

< 0.001

0.400

Carbohydrate (%)

      

PCOS (n = 105)

Controls (n = 111)

54.8 ± 12.4

56.3 ± 4.7

0.400

49.9 ± 6

50.6 ± 5

-4.8 ± 13.8

-5.6 ± 7

< 0.001

0.400

Carbohydrate (gram/day)

      

PCOS (n = 105)

Controls (n = 111)

310.4 ± 56.8

320.9 ± 48.6

0.100

180.6 ± 28.9

184.6 ± 26.7

-129.7 ± 64

-136.2 ± 56.8

< 0.001

0.500

Protein (%)

      

PCOS (n = 105)

Controls (n = 111)

10.1 ± 2

10.2 ± 1.5

0.500

19.9 ± 4.1

20 ± 4.3

9.7 ± 4.1

9.8 ± 4.4

< 0.001

0.700

Protein(gram/day)

      

PCOS (n = 105)

Controls(n = 111)

57.9 ± 11.4

58.3 ± 9.5

0.700

71.6 ± 13.9

72.8 ± 15.4

13.7 ± 17.3

14.4 ± 17.3

< 0.001

0.500

Fat (%)

      

PCOS (n = 105)

Controls (n = 111)

35 ± 13.4

33.3 ± 4.9

0.200

30.1 ± 3.2

29.2 ± 3.4

-4.9 ± 13.7

-4.1 ± 5.7

< 0.001

0.400

Fat (gram/day)

      

PCOS (n = 105)

Controls (n = 111)

93.8 ± 45.8

84.6 ± 17.5

0.060

48.1 ± 4.4

47 ± 5

-45.7 ± 40.9

-37.6 ± 17.5

< 0.001

0.400

GI

      

PCOS (n = 105)

Controls (n = 111)

59.9 ± 5.7

59.2 ± 7.1

0.100

42.6 ± 11.3

44.2 ± 9.4

-17.2 ± 12.5

-14.9 ± 11

< 0.001

0.100

GL

      

PCOS (n = 105)

Controls(n = 111)

147.9 ± 15.6

153.7 ± 33.1

0.200

66 ± 23.6

69.7 ± 20.4

-81.9 ± 28.8

-83.9 ± 37.3

< 0.001

0.600

Physical activity (Met- minute_week)

      

PCOS (n = 105)

Controls (n = 111)

456.4 ± 112.6

438.9 ± 115

0.300

441.3 ± 123.6

443.7 ± 105.3

-15 ± 159.4

4.7 ± 141

0.300

0.200

  1. Data are presented as mean ± SD and number (%). The independent T-test or Mann–Whitney U-test was used to compare the differences between cases and controls. Paired T-test or Wilcoxon signed-rank test was used to define within-group differences
  2. PCOS Polycystic ovary syndrome, Kcal Kilocalories, GI Glycemic index, GL Glycemic load
  3. Significant difference (P < 0.05)